Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$479.76
-0.8%
$471.44
$366.92
$531.79
$11.18B1.19181,869 shs118,101 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$311.87
-2.3%
$307.47
$250.05
$440.38
$8.96B1.47378,755 shs375,011 shs
MSCI Inc stock logo
MSCI
MSCI
$577.56
-0.5%
$566.71
$486.74
$642.45
$44.69B1.32508,140 shs584,883 shs
Zoetis Inc. stock logo
ZTS
Zoetis
$148.61
-0.9%
$160.77
$139.70
$200.33
$66.16B0.912.61 million shs4.72 million shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
0.00%-0.40%+0.86%+1.85%+29.52%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%-3.60%+0.81%+7.92%-25.98%
MSCI Inc stock logo
MSCI
MSCI
0.00%+2.20%+6.01%+8.30%+16.47%
Zoetis Inc. stock logo
ZTS
Zoetis
0.00%-4.07%-5.50%+1.20%-16.78%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
1.4657 of 5 stars
1.21.01.70.01.82.51.9
Medpace Holdings, Inc. stock logo
MEDP
Medpace
4.2795 of 5 stars
2.11.00.04.62.34.22.5
MSCI Inc stock logo
MSCI
MSCI
4.5771 of 5 stars
2.43.04.23.33.22.51.3
Zoetis Inc. stock logo
ZTS
Zoetis
4.9577 of 5 stars
4.45.04.20.42.92.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
2.44
Hold$491.882.53% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.21
Hold$344.8210.56% Upside
MSCI Inc stock logo
MSCI
MSCI
2.77
Moderate Buy$651.5512.81% Upside
Zoetis Inc. stock logo
ZTS
Zoetis
2.70
Moderate Buy$204.6337.69% Upside

Current Analyst Ratings Breakdown

Latest ZTS, KNSL, MEDP, and MSCI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2025
Zoetis Inc. stock logo
ZTS
Zoetis
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/17/2025
Zoetis Inc. stock logo
ZTS
Zoetis
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform$180.00 ➝ $155.00
7/8/2025
MSCI Inc stock logo
MSCI
MSCI
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$655.00 ➝ $700.00
7/8/2025
MSCI Inc stock logo
MSCI
MSCI
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$530.00 ➝ $578.00
6/24/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform ➝ Equal Weight$300.00
6/20/2025
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$543.00
6/18/2025
Zoetis Inc. stock logo
ZTS
Zoetis
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$165.00 ➝ $160.00
5/19/2025
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$490.00 ➝ $525.00
5/12/2025
Zoetis Inc. stock logo
ZTS
Zoetis
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$205.00 ➝ $210.00
5/7/2025
Zoetis Inc. stock logo
ZTS
Zoetis
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$189.00 ➝ $170.00
5/1/2025
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$515.00 ➝ $490.00
(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$1.59B7.04$16.34 per share29.36$63.75 per share7.53
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.11B4.25$13.95 per share22.35$26.56 per share11.74
MSCI Inc stock logo
MSCI
MSCI
$2.86B15.65$18.00 per share32.08($11.99) per share-48.17
Zoetis Inc. stock logo
ZTS
Zoetis
$9.26B7.15$7.07 per share21.02$10.57 per share14.06
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$414.84M$17.3827.6022.811.7824.73%26.36%7.90%7/24/2025 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$404.39M$13.1023.8122.835.6419.31%54.36%20.81%7/21/2025 (Confirmed)
MSCI Inc stock logo
MSCI
MSCI
$1.11B$14.5539.6930.332.8639.08%-145.52%22.74%7/22/2025 (Estimated)
Zoetis Inc. stock logo
ZTS
Zoetis
$2.49B$5.5726.6822.022.4627.12%55.48%19.14%8/5/2025 (Estimated)

Latest ZTS, KNSL, MEDP, and MSCI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Zoetis Inc. stock logo
ZTS
Zoetis
$1.61N/AN/AN/A$2.41 billionN/A
7/24/2025Q2 2025
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$4.36N/AN/AN/A$436.25 millionN/A
7/22/2025Q2 2025
MSCI Inc stock logo
MSCI
MSCI
$4.12N/AN/AN/A$763.06 millionN/A
7/21/2025Q2 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.01N/AN/AN/A$537.70 millionN/A
5/6/2025Q1 2025
Zoetis Inc. stock logo
ZTS
Zoetis
$1.40$1.48+$0.08$1.41$2.20 billion$2.22 billion
4/24/2025Q1 2025
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$3.15$3.71+$0.56$3.83$425.73 million$423.40 million
4/22/2025Q1 2025
MSCI Inc stock logo
MSCI
MSCI
$3.88$4.00+$0.12$3.71$746.45 million$745.83 million
4/21/2025Q1 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.06$3.67+$0.61$3.67$528.38 million$558.57 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$0.680.14%N/A3.91%2 Years
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
MSCI Inc stock logo
MSCI
MSCI
$7.201.25%N/A49.48%11 Years
Zoetis Inc. stock logo
ZTS
Zoetis
$2.001.35%N/A35.91%14 Years

Latest ZTS, KNSL, MEDP, and MSCI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/22/2025
Zoetis Inc. stock logo
ZTS
Zoetis
quarterly$0.501.2%7/18/20257/18/20259/3/2025
5/23/2025
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$0.170.15%5/29/20255/30/20256/12/2025
4/23/2025
MSCI Inc stock logo
MSCI
MSCI
quarterly$1.801.3%5/16/20255/16/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
0.12
0.11
0.11
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.73
0.73
MSCI Inc stock logo
MSCI
MSCI
N/A
0.84
0.84
Zoetis Inc. stock logo
ZTS
Zoetis
1.12
1.74
1.04

Institutional Ownership

CompanyInstitutional Ownership
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
85.36%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
MSCI Inc stock logo
MSCI
MSCI
89.97%
Zoetis Inc. stock logo
ZTS
Zoetis
92.80%

Insider Ownership

CompanyInsider Ownership
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
5.50%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.30%
MSCI Inc stock logo
MSCI
MSCI
3.31%
Zoetis Inc. stock logo
ZTS
Zoetis
0.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
47023.31 million22.03 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
5,90028.74 million22.91 millionOptionable
MSCI Inc stock logo
MSCI
MSCI
6,13277.37 million74.81 millionOptionable
Zoetis Inc. stock logo
ZTS
Zoetis
13,800445.21 million444.50 millionOptionable

Recent News About These Companies

Leerink Partnrs Weighs in on Zoetis' Q3 Earnings (NYSE:ZTS)
Leerink Partners Downgrades Zoetis (NYSE:ZTS) to Market Perform
Zoetis (NYSE:ZTS) Lowered to Hold Rating by Leerink Partnrs

New MarketBeat Followers Over Time

Media Sentiment Over Time

Kinsale Capital Group stock logo

Kinsale Capital Group NYSE:KNSL

$479.76 -3.98 (-0.82%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$479.92 +0.17 (+0.03%)
As of 07:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Kinsale Capital Group, Inc., a specialty insurance company, engages in the provision of property and casualty insurance products in the United States. The company's commercial lines offerings include commercial property, small business casualty and property, excess and general casualty, construction, allied health, life sciences, entertainment, energy, environmental, excess professional, health care, public entity, commercial auto, inland marine, aviation, ocean marine, product recall, and railroad, as well as product, professional, and management liability insurance. It markets and sells its insurance products in all 50 states, the District of Columbia, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands primarily through a network of independent insurance brokers. The company was founded in 2009 and is headquartered in Richmond, Virginia.

Medpace stock logo

Medpace NASDAQ:MEDP

$311.87 -7.29 (-2.28%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$311.83 -0.04 (-0.01%)
As of 07:18 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

MSCI stock logo

MSCI NYSE:MSCI

$577.56 -2.62 (-0.45%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$581.90 +4.34 (+0.75%)
As of 07:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MSCI Inc., together with its subsidiaries, provides critical decision support tools and solutions for the investment community to manage investment processes worldwide. The Index segment provides indexes for use in various areas of the investment process, including indexed financial product, such as ETFs, mutual funds, annuities, futures, options, structured products, and over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct. The Analytics segment offers risk management, performance attribution and portfolio management content, application, an integrated view of risk and return service, and an analysis of market, credit, liquidity, counterparty, and climate risk across asset classes; managed services, including consolidation of client portfolio data, review and reconciliation of input data and results, and customized reporting; and HedgePlatform to measure, evaluate, and monitor the risk of hedge fund investments. The ESG and Climate segment provides products and services that help institutional investors understand how ESG impacts the long-term risk and return of their portfolio and individual security-level investments; and data, ratings, research, and tools to help investors navigate increasing regulation. The All Other Private Assets segment includes real estate and infrastructure data, benchmarks, return-analytics, climate assessments and market insights; business intelligence to real estate owners, managers, developers, and brokers; and offers investment decision support tools for private capital. The Private Capital Solutions segment offers tools to help private asset investors across mission-critical workflows, such as sourcing terms and conditions, evaluating operating performance, managing risk and other activities supporting private capital investing. MSCI Inc. was incorporated in 1998 and is headquartered in New York, New York.

Zoetis stock logo

Zoetis NYSE:ZTS

$148.61 -1.42 (-0.95%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$148.75 +0.14 (+0.09%)
As of 07:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.